Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness

Journal of Cerebral Blood Flow and Metabolism

Volumn 17, Issue 3, 1997, Pages 331-342

  Wong, Dean F ^a,b,i   Pearlson, Godfrey D ^c   Tune, Larry E ^c   Young, L Trevor ^a   Meltzer, Carolyn Cidis ^a   Dannals, Robert F ^a,b   Ravert, Hayden T ^a   Reith, Jakob ^f   Kuhar, Michael J ^b,c,d,h   Gjedde, Albert ^e,g  

^a Division of Nuclear Medicine   (United States)

^b Div of Radiation Health Sciences   (United States)

^c Department of Psychiatry ^*  (United States)

^d NIDA Addiction Research Center   (United States)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f BISPEBJERG HOSPITAL   (Denmark)

^g MCGILL UNIVERSITY   (Canada)

^h EMORY UNIVERSITY   (United States)

ⁱ DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Bipolar illness; D4 dopamine receptors; Dopamine; Dopamine receptors; Positron emission tomography; Psychosis; Receptor quantification; Schizophrenia

Indexed keywords

3 METHYLSPIPERONE C 11; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; HALOPERIDOL;

ADULT; AGING; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MANIC DEPRESSIVE PSYCHOSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOSIS; RECEPTOR DENSITY; SCHIZOPHRENIA;

EID: 0030889598     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-199703000-00010     Document Type: Article

References (44)

1. 2 receptors in the human striatum. Schizophrenia Bull 14:471-484
2. Cressie NAC, Keightly DD (1981) Analyzing data from hormone-receptor assays. Biometrics 37:235-249
3. 2 receptors in schizophrenia studied in vivo. Lancet 2:224-225
4. 2 dopamine receptors in neuroleptic-naive schizophrenic patients. Arch Gen Psychiatry 47:213-219
5. Gjedde A, Wong DF (1990) Modeling neuroreceptor binding of radioligands In Vivo. In: Quantitative Imaging: Neuroreceptors, Neurotransmitters, and Enzymes, (Frost JJ, Wagner HN Jr., eds), New York, Raven Press, pp 51-79
6. Gjedde A, Reith J, Wong D (1995) Dopamine receptors in schizophrenia. Lancet 346:1302-1303
7. Hess EJ, Bracha S, Kleinman JE, Creese I (1987) Dopamine receptor subtype imbalance in schizophrenia. Life Sci 40:1487-1497
8. 2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography. Arch Gen Psychiatry 51:116-123
9. 2 receptor binding in late paraphrenia. Lancet 342:562
10. Kleinbaum DG, Kupper LL, Muller E (1988) Applied Regression Analysis and Other Multivariate Methods, 2nd ed. Boston, PWS Publishers, Ch 14, pp 260-296
11. 2 receptors. Am J Psychiatry 148:1607-1608
12. 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms. J Neural Transm Gen Sect 75:1-10
13. Laruelle M, Van Dyck CH, Abi-Dargham A, et al. (1995) SPECT imaging of dopamine release following amphetamine challenge in healthy subjects and in patients with schizophrenia [Abstract] J Nucl Med 36:10P
14. 2 receptor selectivity of dopamine receptor antagonist: possible therapeutic implications. Eur J Pharmacol 236: 483-486
15. 3H]-NGD-94-1. Schizophr Res 18:173
16. Lee T, Seeman P (1980) Elevation of brain neuroleptic/dopamine receptors in schizophrenia. Am J Psychiatry 137:191-197
17. 76Br]bromospiperone in untreated schizophrenics. Am J Psychiatry 147:44-50
18. 76Br-bromolisuride, Br J Psychiatry 158:346-350
19. 2 receptors in chronic schizophrenics. Biol Psychiatry 21:1407-1414
20. 4 dopamine receptors in postmortem striatum from patients with schizophrenia. J Neurosci 15:2,186-2,191
21. 11C]N-methylspiperone. Psychiatry Res 61:67-83
22. Owen F, Cross AJ, Crow TJ, et al. (1978) Increased dopamine-receptor sensitivity in schizophrenia. Lancet 2:223-226
23. 2 dopamine receptor PET and structural MRI changes in late onset schizophrenia. Schizophr Bull 19:783-795
24. 2 dopamine receptor density in psychotic and non-psychotic patients with bipolar disorder. Arch Gen Psychiatry 52:471-477
25. 123I-IBZM single photon emission computerized tomography study. Br J Psychiatry 164:16-26
26. Reith J, Benkelfat C, Sherwin A, et al. (1994) Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proc Natl Acad Sci USA 91:11,651-11,654
27. Reynolds G, Mason S. (1994) Are striatal dopamine D4 receptors increased in schizophrenia? J Neurochemistry 63:1,576-1,577
28. Seeman P, Ulpian C, Bergeron C, et al. (1984) Bimodal distribution of dopamine receptor densities in brains of schizophrenics. Science 225:728-731
29. Seeman P, Bzowej NH, Guan HC, et al. (1987a) Human brain dopamine receptors in children and aging adults. Synapse 1:399-404
30. 2 dopamine receptors in schizophrenia. Alzheimer's, Parkinson's, and Huntington's diseases. Neuropsychopharmacology 1:5-15
31. 4 receptors elevated in schizophrenia. Nature 365:441-445
32. 125I]epidepride. Eur J Pharmacol 286:R3-R5
33. 4. Neuropsychopharmacology (in press).
34. 18F-haloperidol. J Labelled Compounds Radiopharmaceuticals 26:386
35. 11C-N-methylspiperone. Psychiatry Res 49:219-237
36. Wong DF, Wagner HN Jr, Dannals RF, et al. (1984) Effects of age on dopamine and serotonin receptors measured by positron tomography in living human brain. Science 226:1,393
37. Wong DF, Wagner HN Jr, Pearlson G, et al. (1985) Dopamine receptor binding of C-11 3-N-methylspiperone in the caudate in schizophrenia and bipolar disorder: a preliminary report. Psychopharmacol Bull 21:595-598
38. Wong DF, Gjedde A, Wagner HN Jr (1986a) Quantification of neuroreceptors in the living human brain. I. Association rate of irreversibly bound ligands. J Cereb Blood Flow Metab 6:137-146
39. Wong DF, Gjedde A, Wagner HN Jr, et al. (1986b) Quantification of neuroreceptors in living human brain. II. Inhibition studies of receptor density and affinity. J Cereb Blood Flow Metab 6:147-153
40. 2 dopamine receptors in drug naive schizophrenics. Science 234:1558-1563
41. Wong DF, Tune L, Pearlson G, et al. (1990) Dopamine receptor elevations in drug naive schizophrenia and bipolar affective illness measured by C-11 NMSP PET studies. Clin Neuropharmacol 13(suppl):85
42. 2-like dopamine receptors: theory, validation, and changes during normal aging. J Cereb Blood Flow Metab 17:316-330
43. Wong DF, Hong C, Yokoi F, et al. (1995) Imaging human intrasynaptic dopamine release by IV cocaine and amphetamine. [Abstract] J Nucl Med 36:10P
44. Young LT, Wong DF, Goldman S, et al. (1991) Effects of endogenous dopamine on kinetics of [3H]-N-methylspiperone on [3H] raclopride binding in rat brain. Synapse 9:188-194